Skip to main content
PMC home page
Clinical and Diagnostic Laboratory Immunology logoLink to Clinical and Diagnostic Laboratory Immunology
. 1995 May;2(3):330–336. doi: 10.1128/cdli.2.3.330-336.1995

Determination of CD4 and CD8 lymphocyte subsets by a new alternative fluorescence immunoassay.

T N Denny 1, B D Jensen 1, E I Gavin 1, A G Louzao 1, F A Vella 1, J M Oleske 1, W Wong 1
PMCID: PMC170155  PMID: 7664180

Abstract

The purpose of this study was to evaluate a new alternative fluorescence immunoassay method (Zymmune CD4/CD8 Cell Monitoring Kit; Zynaxis, Inc., Malvern, Pa.) for determining the absolute CD4+ and CD8+ T-lymphocyte concentrations in whole blood. The investigation was performed as a two-site comparison of the reference whole blood flow cytometric method with the Zymmune method. In this investigation, a total of 166 patient samples were evaluated of which approximately 20% were from human immunodeficiency virus-positive individuals. The mean value for samples performed by the Zymmune CD4 assay was 1,094 (range, 74 to 2,586) cells per microliters, while the reference method yielded a mean of 890 (range, 35 to 2,033) cells per microliter. The correlation coefficient for regression analysis was 0.940. The mean value for samples performed by the Zymmune CD8 assay was 700 (range, 212 to 1,813) cells per microliter, while the reference method yielded a mean of 546 (range, 82 to 2,158) cells per microliter. The correlation coefficient for regression analysis was 0.921. No site-specific differences or trends in CD4 or CD8 values were seen when the data were analyzed by site of collection. The average precision of the CD4 assay varied from 6 to 14%, corresponding to the high and low concentration ranges. For CD8, the average precision varied from 8.3 to 16% over the respective high to low concentration ranges. We conclude that the Zymmune CD4/CD8 Cell Monitoring Kit method provides absolute CD4+ and CD8+ T-lymphocyte concentrations which are equivalent to those given by the reference flow cytometric method.

Full Text

The Full Text of this article is available as a PDF (222.3 KB).

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Calvelli T., Denny T. N., Paxton H., Gelman R., Kagan J. Guideline for flow cytometric immunophenotyping: a report from the National Institute of Allergy and Infectious Diseases, Division of AIDS. Cytometry. 1993 Oct;14(7):702–715. doi: 10.1002/cyto.990140703. [DOI] [PubMed] [Google Scholar]
  2. Connor E., Bagarazzi M., McSherry G., Holland B., Boland M., Denny T., Oleske J. Clinical and laboratory correlates of Pneumocystis carinii pneumonia in children infected with HIV. JAMA. 1991 Apr 3;265(13):1693–1697. [PubMed] [Google Scholar]
  3. De Wolf F., Roos M., Lange J. M., Houweling J. T., Coutinho R. A., van der Noordaa J., Schellekens P. T., Goudsmit J. Decline in CD4+ cell numbers reflects increase in HIV-1 replication. AIDS Res Hum Retroviruses. 1988 Dec;4(6):433–440. doi: 10.1089/aid.1988.4.433. [DOI] [PubMed] [Google Scholar]
  4. Fahey J. L., Taylor J. M., Detels R., Hofmann B., Melmed R., Nishanian P., Giorgi J. V. The prognostic value of cellular and serologic markers in infection with human immunodeficiency virus type 1. N Engl J Med. 1990 Jan 18;322(3):166–172. doi: 10.1056/NEJM199001183220305. [DOI] [PubMed] [Google Scholar]
  5. Fischl M. A., Richman D. D., Hansen N., Collier A. C., Carey J. T., Para M. F., Hardy W. D., Dolin R., Powderly W. G., Allan J. D. The safety and efficacy of zidovudine (AZT) in the treatment of subjects with mildly symptomatic human immunodeficiency virus type 1 (HIV) infection. A double-blind, placebo-controlled trial. The AIDS Clinical Trials Group. Ann Intern Med. 1990 May 15;112(10):727–737. doi: 10.7326/0003-4819-112-10-727. [DOI] [PubMed] [Google Scholar]
  6. Gelman R., Cheng S. C., Kidd P., Waxdal M., Kagan J. Assessment of the effects of instrumentation, monoclonal antibody, and fluorochrome on flow cytometric immunophenotyping: a report based on 2 years of the NIAID DAIDS flow cytometry quality assessment program. Clin Immunol Immunopathol. 1993 Feb;66(2):150–162. doi: 10.1006/clin.1993.1019. [DOI] [PubMed] [Google Scholar]
  7. Giorgi J. V., Nishanian P. G., Schmid I., Hultin L. E., Cheng H. L., Detels R. Selective alterations in immunoregulatory lymphocyte subsets in early HIV (human T-lymphotropic virus type III/lymphadenopathy-associated virus) infection. J Clin Immunol. 1987 Mar;7(2):140–150. doi: 10.1007/BF00916008. [DOI] [PubMed] [Google Scholar]
  8. Koepke J. A., Landay A. L. Precision and accuracy of absolute lymphocyte counts. Clin Immunol Immunopathol. 1989 Jul;52(1):19–27. doi: 10.1016/0090-1229(89)90189-x. [DOI] [PubMed] [Google Scholar]
  9. Kovacs A., Frederick T., Church J., Eller A., Oxtoby M., Mascola L. CD4 T-lymphocyte counts and Pneumocystis carinii pneumonia in pediatric HIV infection. JAMA. 1991 Apr 3;265(13):1698–1703. [PubMed] [Google Scholar]
  10. Landay A., Ohlsson-Wilhelm B., Giorgi J. V. Application of flow cytometry to the study of HIV infection. AIDS. 1990 Jun;4(6):479–497. doi: 10.1097/00002030-199006000-00001. [DOI] [PubMed] [Google Scholar]
  11. Lang W., Perkins H., Anderson R. E., Royce R., Jewell N., Winkelstein W., Jr Patterns of T lymphocyte changes with human immunodeficiency virus infection: from seroconversion to the development of AIDS. J Acquir Immune Defic Syndr. 1989;2(1):63–69. [PubMed] [Google Scholar]
  12. Leibovitz E., Rigaud M., Pollack H., Lawrence R., Chandwani S., Krasinski K., Borkowsky W. Pneumocystis carinii pneumonia in infants infected with the human immunodeficiency virus with more than 450 CD4 T lymphocytes per cubic millimeter. N Engl J Med. 1990 Aug 23;323(8):531–533. doi: 10.1056/NEJM199008233230807. [DOI] [PubMed] [Google Scholar]
  13. Malone J. L., Simms T. E., Gray G. C., Wagner K. F., Burge J. R., Burke D. S. Sources of variability in repeated T-helper lymphocyte counts from human immunodeficiency virus type 1-infected patients: total lymphocyte count fluctuations and diurnal cycle are important. J Acquir Immune Defic Syndr. 1990;3(2):144–151. [PubMed] [Google Scholar]
  14. Masur H., Ognibene F. P., Yarchoan R., Shelhamer J. H., Baird B. F., Travis W., Suffredini A. F., Deyton L., Kovacs J. A., Falloon J. CD4 counts as predictors of opportunistic pneumonias in human immunodeficiency virus (HIV) infection. Ann Intern Med. 1989 Aug 1;111(3):223–231. doi: 10.7326/0003-4819-111-3-223. [DOI] [PubMed] [Google Scholar]
  15. Nordon R. E., Milthorpe B. K., Schindhelm K., Slowiaczek P. R. An experimental model of affinity cell separation. Cytometry. 1994 May 1;16(1):25–33. doi: 10.1002/cyto.990160105. [DOI] [PubMed] [Google Scholar]
  16. Saez M. J., de Frutos M., Martinez P., Soriano V. Evaluation of a new fluorescence immunoassay for CD4+ and CD8+ T cell counts in clinical samples. Vox Sang. 1994;67(1):86–87. doi: 10.1111/j.1423-0410.1994.tb05049.x. [DOI] [PubMed] [Google Scholar]
  17. Schenker E. L., Hultin L. E., Bauer K. D., Ferbas J., Margolick J. B., Giorgi J. V. Evaluation of a dual-color flow cytometry immunophenotyping panel in a multicenter quality assurance program. Cytometry. 1993;14(3):307–317. doi: 10.1002/cyto.990140311. [DOI] [PubMed] [Google Scholar]

Articles from Clinical and Diagnostic Laboratory Immunology are provided here courtesy of American Society for Microbiology (ASM)

RESOURCES